Palvella Therapeutics, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
PVLA on Nasdaq
Industry
Pharmaceutical Preparations
Location
125 Strafford Ave, Suite 360, Wayne, PA

Insiders trading volume in the past year

Palvella Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
George M. Jenkins Director $3.96M +$153K +4% Jun 10, 2025
ADAR1 Capital Management, LLC 10%+ Owner $2.3M Aug 9, 2024
Dellora Investments LP no longer 10% owner $2.24M Dec 13, 2024
Todd C. Davis Director $1.79M Jun 10, 2025
Elaine J. Heron Director $815K Jun 10, 2025
Bvf Partners L P/Il Other* $619K Dec 13, 2024
Wes Kaupinen President and CEO, Director $574K Feb 5, 2025
Tim Demuth Chief Medical Officer $5.1K May 13, 2022
James A. Geraghty Director $0 Dec 12, 2024
Tadd S. Wessel Director Jun 10, 2025
Ashley Kline Chief Commercial Officer May 27, 2025
Christopher Kiritsy Director Jun 10, 2025
Hitto Kaufmann Chief Scientific Officer Feb 24, 2023
Thomas Bures Chief Financial Officer Feb 24, 2023
Ann Barbier Director Jun 21, 2023
Jeffrey S. Martini Chief Scientific Officer Feb 5, 2025
Palvella Therapeutics, Inc. Chief Scientific Officer Feb 5, 2025
Kathleen Goin Chief Operating Officer Feb 5, 2025
Matthew L. Sherman Director Jun 21, 2023
Peter A. Kiener Director Jun 21, 2023
Michael Richman Director Jun 21, 2023
Matthew Korenberg CFO and Treasurer Feb 5, 2025
Maya R. Said Director Jun 21, 2023
Shane Olwill Chief Development Officer Feb 24, 2023
Ahmed Mousa Chief Business Officer Feb 24, 2023
Stephen S. Yoder Chief Executive Officer, Director Feb 24, 2023

Recent Insider Transactions by Companies or Individuals for Palvella Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.